{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:50:44Z","timestamp":1793407844398,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,12,19]],"date-time":"2016-12-19T00:00:00Z","timestamp":1482105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,12,19]],"date-time":"2016-12-19T00:00:00Z","timestamp":1482105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1038\/bmt.2016.259","type":"journal-article","created":{"date-parts":[[2016,12,19]],"date-time":"2016-12-19T10:25:26Z","timestamp":1482143126000},"page":"270-278","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR study"],"prefix":"10.1038","volume":"52","author":[{"given":"R T","family":"Maziarz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Brazauskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A A","family":"McLeod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J R","family":"Wingard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Aljurf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Battiwalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C C","family":"Dvorak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Geroge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E C","family":"Guinan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G A","family":"Hale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H M","family":"Lazarus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-W","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J L","family":"Liesveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Ramanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B N","family":"Savani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F O","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Strasfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R A","family":"Taplitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Ustun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M J","family":"Boeckh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Gea-Banacloche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C A","family":"Lindemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J J","family":"Auletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M L","family":"Riches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,19]]},"reference":[{"key":"BFbmt2016259_CR1","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1086\/651263","volume":"50","author":"DP Kontoyiannis","year":"2010","unstructured":"Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the transplant associated infection surveillance network (TRANSNET) database. Clin Infect Dis 2010; 50: 1091\u20131100.","journal-title":"Clin Infect Dis"},{"key":"BFbmt2016259_CR2","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/j.1365-2141.2007.06812.x","volume":"139","author":"PD Barnes","year":"2007","unstructured":"Barnes PD, Marr KA . Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients. Br J Haematol 2007; 139: 519\u2013531.","journal-title":"Br J Haematol"},{"key":"BFbmt2016259_CR3","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1080\/10428190310001625719","volume":"45","author":"B Hayes-Lattin","year":"2004","unstructured":"Hayes-Lattin B, Maziarz RT . Update in the epidemiology, pophylaxis, and treatment of fungal infections in patients with hematologic disorders. Leuk Lymph 2004; 45: 669\u2013680.","journal-title":"Leuk Lymph"},{"key":"BFbmt2016259_CR4","doi-asserted-by":"publisher","first-page":"400","DOI":"10.7326\/0003-4819-147-6-200709180-00010","volume":"147","author":"L Sung","year":"2007","unstructured":"Sung L, Nathan PC, Alibhai SM, Tomlinson GA, Beyene J . Meta-analysis: effect of prophylactic hematopoietic colony-stimulating factors on mortality and outcomes of infection. Ann Intern Med 2007; 147: 400\u2013411.","journal-title":"Ann Intern Med"},{"key":"BFbmt2016259_CR5","doi-asserted-by":"publisher","first-page":"5111","DOI":"10.1182\/blood-2010-02-268151","volume":"116","author":"JR Wingard","year":"2010","unstructured":"Wingard JR, Carter SL, Walsh TJ, Kurtzberg J, Small TN, Baden LR et al. Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation. Blood and Marrow Transplant Clinical Trials Network. Blood 2010; 116: 5111\u20135118.","journal-title":"Blood"},{"key":"BFbmt2016259_CR6","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1056\/NEJMoa020191","volume":"347","author":"R Herbrecht","year":"2002","unstructured":"Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347: 408\u2013415.","journal-title":"N Engl J Med"},{"key":"BFbmt2016259_CR7","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/bmt.2009.259","volume":"44","author":"KA Marr","year":"2009","unstructured":"Marr KA, Bow E, Chiller T, Maschmeyer G, Ribaud P, Segal B et al. Fungal infection prevention after hematopoietic cell transplantation. Bone Marrow Transplant 2009; 44: 483\u2013487.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016259_CR8","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1046\/j.1365-2141.2001.02747.x","volume":"113","author":"S Hermann","year":"2001","unstructured":"Hermann S, Klein SA, Jacobi V, Thalhammer A, Bialleck H, Duchscherer M et al. Older patients with high-risk fungal infections can be successfully allografted using non-myeloablative conditioning in combination with intensified supportive care regimens. Br J Haematol 2001; 113: 446\u2013454.","journal-title":"Br J Haematol"},{"key":"BFbmt2016259_CR9","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/bmt.2008.313","volume":"43","author":"V Bachanova","year":"2009","unstructured":"Bachanova V, Brunstein CG, Burns LJ, Miller JS, Luo X, Defor T et al. Fewer infections and lower infection-related mortality following non-myeloablative versus myeloablative conditioning for allotransplantation of patients with lymphoma. Bone Marrow Transplant 2009; 43: 237\u2013244.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016259_CR10","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/j.transproceed.2008.03.149","volume":"40","author":"ZS Aki","year":"2008","unstructured":"Aki ZS, Sucak GT, Ye\u011fin ZA, Guzel O, Erbas G, Senol E . Hematopoietic stem cell transplantation in patients with active fungal infection: not a contraindication for transplantation. Transplant Proc 2008; 40: 1579\u20131585.","journal-title":"Transplant Proc"},{"key":"BFbmt2016259_CR11","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.bbmt.2004.02.006","volume":"10","author":"T Fukuda","year":"2004","unstructured":"Fukuda T, Boeckh M, Guthrie KA, Mattson DK, Owens S, Wald A et al. Invasive aspergillosis before allogeneic hematopoietic stem cell transplantation: 10-year experience at a single transplant center. Biol Blood Marrow Transplant 2004; 10: 494\u2013503.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2016259_CR12","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.1182\/blood-2006-03-008706","volume":"108","author":"R Martino","year":"2006","unstructured":"Martino R, Parody R, Fukuda T, Maertens J, Theunissen K, Ho A et al. Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: A retrospective survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Blood 2006; 108: 2928\u20132936.","journal-title":"Blood"},{"key":"BFbmt2016259_CR13","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/bmt.2015.237","volume":"51","author":"O Penack","year":"2016","unstructured":"Penack O, Tridello G, Hoek J, Socie G, Blaise D, Passweg J et al. Influence of pre-existing invasive aspergillosis on allo-HSCT outcome: a retrospective EBMT analysis by the Infectious Diseases and Acute Leukemia Working Parties. Bone Marrow Transplantation 2016; 51: 418\u2013423.","journal-title":"Bone Marrow Transplantation"},{"key":"BFbmt2016259_CR14","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1080\/10428190500097052","volume":"46","author":"SJ Vaidya","year":"2005","unstructured":"Vaidya SJ, Ort\u00edn M, L\u00f3pez-Duarte M, Sirsohi B, Powles R, Treleaven J et al. Haemopoietic progenitor cell transplantation in patients with previous history of invasive fungal infection. Leuk Lymphoma 2005; 46: 1143\u20131150.","journal-title":"Leuk Lymphoma"},{"key":"BFbmt2016259_CR15","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.bbmt.2014.03.004","volume":"20","author":"C Girmenia","year":"2014","unstructured":"Girmenia C, Raiola AM, Piciocchi A, Stanzani M, Cudillo L, Pecoraro C et al. Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO). Biol Blood Marrow Transplant 2014; 20: 872\u2013880.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2016259_CR16","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.bbmt.2014.02.018","volume":"20","author":"D Girmenia","year":"2014","unstructured":"Girmenia D, Barosi G, Piciocchi A, Arcese W, Aversa F, Bacigalupo A et al. Primary prophylaxis of invasive fungal diseases in allogeneic stem cell transplantation: revised recommendations from a consensus process by the Gruppo Italiano Trapianto Midollo Osseo (GITMO). Biol Blood Marrow Transplant 2014; 20: 1080\u20131088.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2016259_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/biomet\/90.1.15","volume":"90","author":"PK Andersen","year":"2003","unstructured":"Andersen PK, Klein JP, Rosth\u00f8j S . Generalized linear models for correlated pseudo-observations with applications to multi-state models. Biometrika 2003; 90: 15\u201327.","journal-title":"Biometrika"},{"key":"BFbmt2016259_CR18","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.0006-341X.2005.031209.x","volume":"61","author":"JP Klein","year":"2005","unstructured":"Klein JP, Andersen PK . Regression modeling of competing risks data based on pseudo-values of the cumulative incidence function. Biometrics 2005; 61: 223\u2013229.","journal-title":"Biometrics"},{"key":"BFbmt2016259_CR19","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","volume":"15","author":"A Bacigalupo","year":"2009","unstructured":"Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant 2009; 15: 1628\u20131633.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2016259_CR20","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1056\/NEJMoa061098","volume":"356","author":"AJ Ullmann","year":"2007","unstructured":"Ullmann AJ, Lipton JH, Vesole DH, Chandrasekar P, Langston A, Tarantolo SR et al. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 2007; 356: 335\u2013347.","journal-title":"N Engl J Med"},{"key":"BFbmt2016259_CR21","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1200\/JCO.2012.46.6193","volume":"31","author":"T Hahn","year":"2013","unstructured":"Hahn T, McCarthy PL Jr, Hassebroek A, Bredeson C, Gajewski J, Hale G et al. Significant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors. J Clin Oncol 2013; 31: 2437\u20132449.","journal-title":"J Clin Oncol"},{"key":"BFbmt2016259_CR22","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1056\/NEJMoa1004383","volume":"363","author":"TA Gooley","year":"2010","unstructured":"Gooley TA, Chien JW, Pergam SA, Hingorani S, Sorror ML, Boeckh M et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med 2010; 363: 2091\u20132101 23.","journal-title":"N Engl J Med"},{"key":"BFbmt2016259_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/pbc.23415","volume":"59","author":"CC Dvorak","year":"2012","unstructured":"Dvorak CC, Fisher BT, Sung L, Steinbach WJ, Nieder M, Alexander S et al. Antifungal prophylaxis in pediatric hematology\/oncology: new choices & new data. Pediatr Blood Cancer 2012; 59: 21\u201326.","journal-title":"Pediatr Blood Cancer"},{"key":"BFbmt2016259_CR24","first-page":"941","volume":"11","author":"M Norkin","year":"2013","unstructured":"Norkin M, Wingard JR . Diagnostic strategies for invasive fungal infections in patients with hematologic malignancies and hematopoietic stem cell transplant recipients. JNCCN 2013; 11: 941\u2013949.","journal-title":"JNCCN"},{"key":"BFbmt2016259_CR25","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1099\/jmm.0.073478-0","volume":"63","author":"A Cordeiro Rde","year":"2014","unstructured":"Cordeiro Rde A, Macedo Rde B, Teixeira CE, Marques FJ, Bandeira Tde J, Moreira JL et al. The calcineurin inhibitor cyclosporin A exhibits synergism with antifungals against Candida parapsilosis species complex. J Med Microbiol 2014; 63: 936\u2013944.","journal-title":"J Med Microbiol"},{"key":"BFbmt2016259_CR26","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1099\/jmm.0.081760-0","volume":"64","author":"H Li","year":"2015","unstructured":"Li H, Chen Z, Zhang C, Gao Y, Zhang X, Sun S . Resistance reversal induced by a combination of fluconazole and tacrolimus (FK506) in Candida glabrata. J Med Microbiol 2015; 64: 44\u201352.","journal-title":"J Med Microbiol"},{"key":"BFbmt2016259_CR27","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B De Pauw","year":"2008","unstructured":"De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer \/ Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycosis Study Group (EORTC\/ MSG) consensus group. Clin Infect Dis 2008; 46: 1813\u20131821.","journal-title":"Clin Infect Dis"},{"key":"BFbmt2016259_CR28","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","volume":"15","author":"M Tomblyn","year":"2009","unstructured":"Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 2009; 15: 1143\u20131238.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2016259_CR29","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.bbmt.2015.09.013","volume":"22","author":"JA Young","year":"2016","unstructured":"Young JA, Logan BR, Wu J, Wingard JR, Weisdorf DJ, Mudrick C et al. Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors. Biol Blood Marrow Transplant 2016; 22: 359\u2013370.","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2016259.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2016259","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2016259.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T15:07:23Z","timestamp":1648048043000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2016259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,19]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["BFbmt2016259"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2016.259","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727123154.793526770","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.727123154.793529215","asserted-by":"object"}]},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,19]]},"assertion":[{"value":"12 October 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}